FDA
approval
· 2022-12-16
FDA Approved: BUPRENORPHINE AND NALOXONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
Summary
The FDA approved a supplemental application for Sun Pharmaceutical's buprenorphine/naloxone product. This approval signifies changes to the product under the AN…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BUPRENORPHINE AND NALOXONE (BUPRENORPHINE AND NALOXONE)